Mein wahres Leben: Tipps zum TS
❤️ Click here: Transsexualität forum
Ich bin nicht Schwul und könnte es niemals mit einem Mann treiben. Transsexual people must decide whether to transition on-the-job, or to find a new job when they make their social transition. Falls du aber mit deinem Körper nicht zufrieden bist und in dir der Wunsch nach einem weiblichen Körper hast, solltest du nach Unterstützung suchen.
Having hurting boobs for close to 5 years is not really fun! Estrogen stimulates growth of the nipples, progression of mammary duct branching to the stage at which ductiles are formed, and fatty stromal growth until it constitutes about 85% of the mass of the breast. Androcur , which is unavailable in the United States, is widely used in , , and the rest of the world.
Erfolgreiche transsexuelle Männer(FtM): Links und Fotos - Kann ich ihn auffordern es doch jemanden zu sagen oder würde er das als zusätzlichen Druck empfinden?
It is one of two types of the other being and is predominantly used to treat and other. Some people also take this form of therapy, according to their personal needs and preferences. The transsexualität forum of the therapy is to cause the development of the secondary sex characteristics of the desiredsuch as and a feminine pattern of, and distribution. It cannot undo many of the changes produced by naturally occurringwhich may necessitate and other treatments to reverse see. Introducing exogenous hormones into the body impacts it at every level and many patients report changes in energy levels, mood, appetite, etc. The goal of the transsexualität forum is to provide patients with a more satisfying body that is more congruent with their. Other physicians operate by an model and have no requirements for transgender hormone therapy aside from consent. The accessibility of transgender hormone therapy differs throughout the world and throughout individual countries. Unsourced material may be challenged and removed. December 2018 Some medical conditions may be a reason to not to take feminizing hormone therapy because of the harm it could cause to the individual. Such interfering factors are described in medicine as. Absolute contraindications — those that can cause life-threatening complications, and in which feminizing hormone therapy should never be used — include histories of estrogen-sensitive e. As dosages increase, risks increase as well. Therefore, patients with relative contraindications may start at low dosages and increase gradually. These include to induce and suppress levels; such as,and to further oppose the effects of androgens like testosterone; and for various possible though uncertain benefits. An estrogen in combination with an antiandrogen is the mainstay of feminizing hormone therapy for transgender women. Demonstrates the suppression of testosterone levels by oral estradiol. A variety of different forms of estrogens are available and used medically. The most common estrogens used in transgender women includewhich is the predominant natural estrogen in women, and such as andwhich are of estradiol. Premarinwhich are used inandwhich is used inhave been used in transgender women in the past, but are no longer recommended and are rarely used today due to their higher risks of and problems. In addition to producing feminization, estrogens have effects and suppress production. They are mainly responsible for the suppression of testosterone levels in transgender women. Lower levels of estradiol can also considerably but incompletely suppress testosterone production. When testosterone levels are insufficiently suppressed by estradiol alone, can be used to suppress or block the effects of residual testosterone. Oral estradiol often has difficulty adequately suppressing testosterone levels, due to the relatively low estradiol levels achieved with it. Prior to surgical removal of the gonads orthe doses of estrogens used in transgender women are often higher than replacement doses used in women. This is to help suppress testosterone levels. However, it notes that these physiological levels of estradiol are usually unable to suppress testosterone levels into the female range. A 2018 review proposal questioned the notion of keeping estradiol levels transsexualität forum in transgender women, which results in incomplete suppression of testosterone levels and necessitates the addition of antiandrogens, and noted that high-dose parenteral estradiol is known to be safe. Dosages of estrogens can be reduced after an orchiectomy or sex reassignment surgery, when gonadal testosterone suppression is no longer needed. In addition, androgens stimulate and the frequency of and are responsible for, and. They also have functional effects in the breasts and oppose estrogen-mediatedeven at low levels. Androgens act by binding to and activating thetheir in the body. Antiandrogens that directly block the androgen receptor are known as or blockers, while antiandrogens that the of androgens are known as and antiandrogens that suppress androgen production in the are known as. The purpose of the use of antiandrogens in transgender women is transsexualität forum block or suppress residual testosterone that is not suppressed by estrogens alone. Additional antiandrogen therapy is not necessarily required if testosterone levels are in the normal transsexualität forum range or if the person has undergone. They are the most commonly used antiandrogens in transgender women. transsexualität forum Aldactonewhich is relatively safe and inexpensive, is the most transsexualität forum used antiandrogen in the. Androcurwhich is unavailable in the United States, is widely used in, and the rest of the world. Provera, Depo-Proveraa similar medication, transsexualität forum sometimes used in place of cyproterone acetate in the United States. Spironolactone is an antagonist of the andwhich is mainly used to treat,and caused by otheramong other uses. Spironolactone is an antiandrogen as a secondary and originally unintended action. It works as an antiandrogen mainly by acting as an androgen receptor antagonist. The medication is also a weakand inhibits the of androgens. However, this action is of very lowand spironolactone has mixed and highly inconsistent effects on hormone levels. In any case, testosterone levels are usually unchanged by spironolactone. In accordance, a relatively large study found no effect of spironolactone on testosterone levels in transgender women. Spironolactone is described as a relatively weak antiandrogen. It is widely used in the treatment of, and in women, who have much lower testosterone levels than men. Because of its antimineralocorticoid activity, spironolactone has antimineralocorticoid side effects and can cause. As such, monitoring of potassium levels may not be necessary in most cases. Spironolactone has been found to decrease the of oral estradiol. Although widely employed, the use of spironolactone as an antiandrogen in transgender women has recently been questioned due to the various shortcomings of the medication for such purposes. The estrogen used was 0. Cyproterone acetate is an antiandrogen and progestin which is used in the treatment of numerous and is also used as a progestogen in. It works primarily as an antigonadotropin, secondarily to its potent progestogenic activity, and strongly suppresses gonadal androgen production. In addition to its actions as an antigonadotropin, cyproterone acetate is an androgen receptor antagonist. Cyproterone acetate can cause andincluding. Transsexualität forum, this occurs mostly in prostate cancer patients who take very high doses of cyproterone acetate, and liver toxicity has not been reported in transgender women. Cyproterone acetate also has a variety of othersuch as andand risks, such as andamong others. Periodic monitoring of liver enzymes and levels may be advisable during cyproterone acetate therapy. It is specifically used as an alternative to cyproterone acetate in the United States, where cyproterone acetate is not approved for medical use and is unavailable. Medroxyprogesterone acetate suppresses testosterone levels in transgender women similarly to cyproterone acetate. In contrast to cyproterone acetate however, medroxyprogesterone acetate is not also an androgen receptor antagonist. Medroxyprogesterone acetate has similar side effects and risks as cyproterone acetate, but is not associated with liver problems. Numerous other progestogens and by extension antigonadotropins have been used to suppress testosterone levels in men and are likely useful for such purposes in transgender women as well. The combination of a sufficient dosage of a progestogen with very small doses of an estrogen e. These medications are primarily used in the treatment of prostate cancer, but are also used for other purposes such as the treatment of, and in women. Unlike steroidal antiandrogens, nonsteroidal antiandrogens are highly for the androgen receptor and act as pure androgen receptor antagonists. Similarly to spironolactone however, they do not lower androgen levels, and instead work exclusively by preventing androgens from activating the androgen receptor. The nonsteroidal transsexualität forum that have been used in transgender women include the first-generation medications EulexinAnandron, Nilandronand Casodex. Flutamide and nilutamide have relatively highincluding considerable risks of and. Due to its risks, the use of flutamide in cisgender and transgender women is now limited and transsexualität forum. Flutamide and nilutamide have largely been superseded by bicalutamide in clinical practice, with bicalutamide accounting for almost 90% of nonsteroidal antiandrogen prescriptions in the by the mid-2000s. Bicalutamide is said to have excellent and relative to flutamide and nilutamide, as well as in comparison to cyproterone acetate. It has few to no side effects in women. The medication does have a small risk of elevated liver enzymes and has been associated with very rare cases of liver damage and lung disease however. However, estrogens suppress testosterone levels and at high doses can markedly disrupt sex drive and function and fertility on their own. Moreover, disruption of gonadal function and fertility by estrogens may be permanent transsexualität forum extended exposure. The gonadotropins signal the to make such as testosterone and estradiol. This is in contrast to the rest of and to the. The sixth edition of the 's Standards of Care permit it from Tanner stage 2 but do not allow the addition of hormones until age 16, which could be five or more years later. There are three different of 5α-reductase, types, andand these three isoforms show different patterns of in the body. As such, 5α-reductase serves to considerably potentiate the effects of testosterone. Besides the involvement of 5α-reductase in androgen signaling, it is also required for the conversion of such as, and testosterone into like, andrespectively. Finasteride is a inhibitor of 5α-reductase types 2 and 3, while dutasteride is an inhibitor of all three isoforms of 5α-reductase. Conversely, 5α-reductase inhibitors do not decrease testosterone levels, and may actually increase them slightly. They are also used in the treatment of androgen-dependent scalp hair loss in men and women. The medications are able to prevent further scalp hair loss in men and can restore some scalp hair density. Conversely, the effectiveness of 5α-reductase inhibitors in the treatment of scalp hair loss in women is less clear. This may be because androgen levels are much lower in women, in whom they may not play as important of a role in scalp hair loss. In addition to their antiandrogenic uses, 5α-reductase inhibitors have been found to reduce adverse affective symptoms in in women. This is thought to be due to prevention by 5α-reductase inhibitors of the conversion of progesterone into allopregnanolone during the of the. They may have beneficial effects limited to improvement of scalp hair loss, body hair growth, and possibly skin symptoms such as acne. However, little clinical research on 5α-reductase inhibitors in transgender women has been conducted, and evidence of their efficacy and safety in this group is limited. Moreover, 5α-reductase inhibitors have only mild and specific antiandrogenic activity, and are not recommended as general antiandrogens. In men, the most common side effect is 0. Another side effect in men issuch as and 2. There are reports that a small percentage of men may experience persistent sexual dysfunction and adverse even after discontinuation of 5α-reductase inhibitors. Some of the possible side effects of 5α-reductase inhibitors in men, such as gynecomastia and sexual dysfunction, are actually welcome changes for many transgender women. In any case, caution may be warranted in using 5α-reductase inhibitors in transgender women, as this group is already at a high risk for depression and. It is mainly involved in the regulation of thethe, and. The non-reproductive effects of progesterone are fairly insignificant. Unlike estrogens, progesterone is not known to be involved in the development of femaleand hence is not believed to contribute to in women. One area of particular interest in terms of the effects of progesterone in women is breast development. Estrogens are transsexualität forum for the development of the and of the breasts and the deposition of transsexualität forum the breasts during in girls. Conversely, high levels of progesterone, in conjunction with other hormones such asare responsible for the of the during pregnancy. This allows for lactation and after. Although progesterone causes the breasts to change during pregnancy, the breasts undergo and revert to their pre-pregnancy composition and size after the cessation of breastfeeding. Every pregnancy, lobuloalveolar maturation occurs again anew. There are two types of progestogens: progesterone, which is the and hormone in the body; andwhich are progestogens. There are dozens of clinically used progestins. Certain progestins, namely and and as described previously, are used at high doses as functional due to their effects to help suppress testosterone levels in transgender women. Aside from the specific use of testosterone suppression however, there are no other indications of progestogens in transgender women at present. In relation to this, the use of progestogens in transgender women is controversial, and they are not otherwise routinely prescribed or recommended. Besides progesterone, cyproterone acetate, and medroxyprogesterone acetate, other progestogens that have been reported to have been used in transgender women include, and. Progestins in general largely have the same progestogenic effects however, and in theory, any progestin could be used in transgender women. Clinical research on the use of progestogens in transgender women is very limited. There are no clinical studies to support such reports at present. No clinical study has assessed the use of progesterone transsexualität forum transgender women, and only a couple of studies have compared the use of progestins specifically cyproterone acetate and medroxyprogesterone acetate versus transsexualität forum use of no progestogen in transgender women. These studies, albeit limited in the quality of their findings, reported no benefit of progestogens on breast development in transgender women. transsexualität forum This has also been the case in limited clinical experience. These reports are in accordance with the normal and even above-average breast development in transsexualität forum withwho lack progesterone and have no lobuloalveolar development of the mammary glands on examination. It is noteworthy thatwhich makes up lobuloalveolar tissue, normally outside of pregnancy and lactation comprises only about 10 to 15% of the tissue of the breasts. Although the influence of progesterone on breast development is uncertain, progesterone is thought to cause reversible during the due to local in the breasts. Progestogens have some effects in the breasts, for instance decreasing of the and increasing expression of estrogen-and for this reason, have been used to treat and. Progesterone levels during female puberty do not normally increase importantly until near the end of puberty in cisgender girls, a point by which most or all breast development has already been completed, and there has been some concern that premature exposure to progestogens is unphysiological and might compromise final breast growth. Though the role of progestogens in visible breast development is uncertain, progestogens are essential for lobuloalveolar maturation of the mammary glands, and hence are required for any transgender woman who wishes to lactate or breastfeed. A study found full lobuloalveolar maturation of the mammary glands on histological examination in transgender women treated with an estrogen and high-dose cyproterone acetate. However, the lobuloalveolar development reversed with discontinuation of cyproterone acetate, indicating that continued progestogen exposure is necessary to maintain the tissue. In terms of the effects of progestogens on sex drive, one study assessed the use of dydrogesterone to improve sexual desire in transgender women and found no benefit. Another study likewise found that oral progesterone did not improve sexual function in cisgender women. Oral progesterone has effects and can produce side effects such as, and -like effects. Many progestins havesuch as,and activity, and these activities likewise can contribute unwanted side effects. Furthermore, the addition of a progestin to estrogen therapy has been found to increase the risk ofe. Although it is unknown if these health risks of progestins transsexualität forum in transgender women similarly, it cannot be ruled out that they do. High-dose progestogens increase the risk of including and as well. Because of their potential detrimental effects and lack of supported benefits, some researchers have argued that, aside from the purpose of testosterone suppression, progestogens should not generally be used or advocated in transgender women or should only be used for a limited duration e. Conversely, other researchers have argued that the risks of progestogens in transgender women are likely minimal, and that in light of potential albeit hypothetical benefits, should be used if desired. In general, some transgender women respond favorably to the effects of progestogens, while others respond negatively. Progesterone is most commonly taken orally. However, oral progesterone has very lowand produces only weak and inadequate progestogenic effects even at high doses. In accordance, and in contrast to progestins, oral progesterone has no antigonadotropic effects in men even at high doses. Progesterone can also be taken transsexualität forum various parenteral non-oral routes, including sublingually, rectally, and by intramuscular or subcutaneous injection. These routes do not have the bioavailability and efficacy issues of oral progesterone, and accordingly, can produce considerable antigonadotropic and other progestogenic effects. Transdermal progesterone is poorly effective, owing to absorption issues. Progestins are usually taken orally. In contrast to progesterone, most progestins have high oral bioavailability, and can produce full progestogenic effects with oral administration. Some progestins, such as medroxyprogesterone acetate and hydroxyprogesterone caproate, are or can be used by intramuscular or subcutaneous injection instead. Almost all progestins, with the exception of dydrogesterone, have antigonadotropic effects. The concomitant use of a cytochrome P450 inducer or inhibitor with feminizing hormone therapy may necessitate medication dosage adjustments. Maximum effects vary widely depending on,and status of. Generally, older individuals with intact may have less overall. Temporary can be achieved with,and other methods. Development can take a couple years to nearly a decade for some. For this reason, many seek. Transgender patients opting for are transsexualität forum. Shoulder width and the size of the rib cage also play a role in the perceivable size of the breasts; both are usually larger in transgender women, causing the breasts to appear proportionally smaller. Thus, when a transgender woman opts to have breast augmentation, the used tend to be larger than transsexualität forum used by cisgender transsexualität forum. Incisgender women have used from fat to regrow their breasts after. This could someday eliminate the need for implants for transgender women. Progesterone causes the milk sacs to develop, and with the right stimuli, a transgender woman may lactate. The skin becomes softer, more susceptible to tearing and irritation from scratching or shaving, and slightly lighter in color because of a slight decrease in. Consequently, the skin becomes less prone to acne. It also becomes drier, and lotions or oils may be necessary. The become smaller because of the lower quantities of oil being produced. Many — a type of sweat gland — become inactive, and body odor decreases. Remaining body odor becomes less metallic, sharp, or acrid, and more sweet and musky. Susceptibility to increases, possibly because the skin is thinner and less pigmented. Patients taking antiandrogens tend to have better results with and than those who are not. In patients in their teens or early twenties, antiandrogens prevent new facial hair from developing if testosterone levels transsexualität forum within the normal female range. Arm, perianal, and hair is reduced but may not turn to vellus hair on the latter two regions some cisgender women also have hair in these areas. Underarm hair changes slightly in texture and length, and becomes more typically female in pattern. Lower leg hair becomes less dense. All of these changes depend to some degree on genetics. Head hair may change slightly in texture, curl, and color. This is especially likely with hair growth from previously bald areas. Because of decreased androgen levels, the the sebaceous glands on the upper and lower eyelids that open up at the edges produce less oil. Because oil prevents the from evaporating, this change may cause dry eyes. Fat on the hips, thighs, and buttocks has a higher concentration of and is meant to be used for. The body begins to burn old adipose tissue in the waist, shoulders, and back, making those areas smaller. Subcutaneous fat increases in the andmaking the face appear rounder, with slightly less emphasis on the as the lower portion transsexualität forum the cheeks fills in. Hip discomfort is not uncommon. This can cause a reduction in total body height. If estrogen therapy is begun prior to pelvis ossification, which occurs around the age of 25, the pelvic outlet and inlet open slightly. The also widen, because they are connected to the pelvis. Consequently, it does not affect height; the length of the arms, legs, hands, and feet; or the width of the and. The width of the hips is not affected in individuals for whom fusion and closure of the ends of bones, which prevents any further lengthening has taken place. This occurs in most people between 18 and 25 years of age. A significant majority of craniofacial changes occur during. Post-adolescent growth is considerably slower and minimal by comparison. Also unaffected is the prominence of the. These changes may be reversed by surgery andrespectively. During puberty, the voice deepens in and becomes more. It may, however, be eliminated nearly permanently withor permanently with. Because hormone therapy is usually the first physical step taken to transition, the act of beginning it has a significant psychological effect, which is difficult to distinguish from hormonally induced changes. However, many transgender women report mood benefits as well. A small number of post-operative transgender women take low doses of testosterone to boost their libido. Many pre-operative transgender women wait until after reassignment surgery to begin an active sex life. Raising the dosage of estrogen or adding a progestogen raises the libido of some transgender women. However, it is possible to speculate the outcomes of these therapies on transgender people based on the knowledge of the current effects of gonadal hormones on sexual functioning in men and women. Firstly, if one is to decrease testosterone in male-to-female gender transition, it is likely that sexual desire and arousal would be inhibited; alternatively, if high doses of estrogen negatively impact sexual desire, which has been found in some research with women, it is hypothesized that combining androgens with high levels of estrogen would intensify this outcome. As with any pharmacological or hormone therapy, there are potential side effects, which in the case of transgender hormone therapy include changes in sexual functioning. These have the ability to significantly impact sexual functioning, either directly or indirectly through the various side effects, such as cerebrovascular disorders, obesity, and mood fluctuations. In addition, some research has found an onset of diabetes following feminizing hormone therapy, which impairs sexual response. Whatever route an individual and their doctor choose to take, it is important to consider both the medical risks of hormone therapy as well as the psychological needs of the patient. A 2015 review concluded that hormone therapy for transgender people is safe when supervised by a qualified medical professional. Non-bioidentical estrogens such as conjugated estrogens and especially transsexualität forum have markedly disproportionate effects on liver protein synthesis relative to estradiol. In addition, oral estradiol has a 4- to 5-fold increased impact on liver protein synthesis transsexualität forum does transdermal estradiol and other parenteral estradiol routes. Because the risks of — which is used to treat blood clots — in a relatively young and otherwise healthy population are low, while the risk of adverse physical and psychological outcomes for untreated transgender patients is high, prothrombotic mutations such as, and or are not absolute contraindications for hormonal therapy. A 2018 cohort study of 2842 transfeminine individuals in the treated with a mean follow-up of 4. Other medications such as antiandrogens like spironolactone were also used. For comparison, the rate in the general population has been found to be 1. Cardiovascular health in transgender women has been reviewed in recent publications. They may also increase levels, indicating liver toxicity, especially when taken in oral form. Building muscle takes more work. The transsexualität forum of a progestogen may increase energy, although it may increase appetite as well. Both estrogen and testosterone help to stimulate bone formation, especially during puberty. Estrogen is the predominant sex hormone that slows bone loss, even in men. This is in accordance with research in cisgender men in which has been found not to be associated with an increased risk of breast cancer, suggesting a protective role of the male. On the transsexualität forum hand, men with two X chromosomes and one Y chromosomewhich causes, and a very high incidence of gynecomastia 80%have a dramatically 20- to transsexualität forum increased risk of breast cancer compared to men with one X chromosome, closer to the rate of females. Whereas as many as 70% of men show prostate cancer by their 80s, only a handful of cases of prostate cancer in transgender women have been reported in the literature. The risks of hormone-sensitive cancers in transgender women have been reviewed. Milk discharge from the nipples can be a sign of. If a prolactinoma becomes large enough, it can cause visual changes especially decreased, depression or other mood changes,and symptoms oflike. Physicians also recommend broader medical monitoring, including ; tests of renal function, liver function, and lipid and glucose metabolism; and monitoring of prolactin levels, body weight, and blood pressure. University of California, San Francisco: Center of Excellence for Transgender Health. Alexander; Versie Johnson-Mallard; Elizabeth Kostas-Polston; Catherine Ingram Fogel, Nancy Fugate Woods 28 June 2017. The Journal of Clinical Endocrinology and Metabolism. Cochrane Database of Systematic Reviews. Endocrinology of the Testis and Male Reproduction. Encyclopedia transsexualität forum Molecular Cell Biology and Molecular Medicine. De Groot 18 May 2010. Bull Am Acad Psychiatry Law. When used in a dose of 40 mg tid, in combination with estradiol 0. Eur Rev Med Pharmacol Sci. Karger Medical and Scientific Publishers. Traditionally, patients have been advised to cryopreserve sperm prior to starting cross-sex hormone therapy as there is a potential for a decline in sperm motility with high-dose estrogen therapy over time Lubbert et al. However, this decline in fertility due to estrogen therapy is controversial due to limited studies. Estrogens are highly efficient inhibitors of the transsexualität forum axis 212—214. Aside from their negative feedback action at the level of the hypothalamus and pituitary, direct inhibitory effects on the testis are likely 215,216. This prolonged suppression is thought to result from a direct effect of estrogens on the Leydig cells. Nat Clin Pract Endocrinol Metab. De Groot 25 February 2015. Curr Opin Endocrinol Diabetes Obes. Horm Mol Biol Clin Investig. Curr Opin Endocrinol Diabetes Obes. Transsexualität forum Won-Soo Lee 13 February 2014. Wiley Interdisciplinary Reviews: Developmental Biology. Tarver; Joy Diane Shaffer 1 March 2001. It has been suggested that progestins be added during the last week of each cycle of estrogen therapy in order to develop more rounded breasts rather than the conical breasts many of these patients develop, but we have been unable to detect any difference in breast contour with or without progestins. Adipocytes make up the bulk of the human breast, with epithelial cells accounting for only approximately 10% of human breast volume. transsexualität forum Journal of Mammary Gland Biology and Neoplasia. In the stroma, there is an increase in the amount of fibrous and fatty tissue, with the adult nonlactating breast consisting of 80% or more of stroma. Estrogen stimulates the nipples to grow, mammary terminal duct branching to progress to the stage at which ductules are formed, and fatty stromal growth to increase until it constitutes about 85% of the mass of the breast. These effects are due to the presence of progesterone. Journal of Pediatric and Adolescent Gynecology. Estrogen stimulates growth of the nipples, progression of mammary duct branching to the stage at which ductiles are formed, and fatty stromal growth until it constitutes about 85% of the mass of the breast. Throughout the reproductive years, some women note swelling of the breast around the latter part of each menstrual cycle before the onset of menstruation. The water retention and subsequent swelling of breast tissue during this phase of the menstrual cycle are thought to be due to high levels of circulating progesterone stimulating the secretory cells of the breast. Recently, an attempt has been made by Foss 1956 to initiate lactation in a castrated male transvestist. He was given an implant of 500 milligrams of oestradiol, and 10 months later, a further 600 milligrams of oestradiol, followed by daily injections of oestradiol dipropionate and progesterone for 6 weeks. Immediately after withdrawal of this treatment, 22·9 milligrams of prolactin were injected daily for 3 days but without effect. After a second month of treatment with oestradiol and progesterone daily, he was given combined injections of prolactin and somatotrophin for 4 days, suction with a breast-pump being employed 4 times daily. On the fourth and fifth days a few drops of colostrum were expressed from the right nipple. There is a possible application here of modern hormone knowledge to man, and further trials would be of interest. The American Journal of Surgical Pathology. The Health of Sexual Minorities: 473—505. Journal für Reproduktionsmedizin und Endokrinologie-Journal of Reproductive Medicine and Endocrinology. Wayne Meikle 1 June 1999. Archived from on 3 June 2012. Journal of Clinical Endocrinology and Metabolism. The Journal of Reproductive Medicine. American Journal of Optometry and Physiological Optics. The Journal of Clinical Endocrinology and Metabolism. Annals of the New York Academy of Sciences. Journal Français d'Ophtalmologie in French. Int J Technol Assess Health Care. Fritz; Leon Speroff 28 March 2012. University of California, San Francisco: Center of Excellence for Transgender Health.
Transsexualität im Iran
So mittlerweile bin ich wirklich frustriert, da es mich sehr Physisch belastet. Provera, Depo-Provera , a similar medication, is sometimes used in place of cyproterone acetate in the United States. Flutamide and nilutamide have relatively high , including considerable risks of and. Spironolactone is described as a relatively weak antiandrogen. Viele sind diesen Weg gegangen und wurden auch glücklich. She withdrew from me completely. Michael Bailey's, welches transsexuelle Frauen herabwürdigt und karikiert.
